First FDA-cleared autonomous AI makes new moves in healthcare diagnostics

Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! In 2018, Iowa-based Digital Diagnostics made headlines when it became the first autonomous AI (artificial intelligence) system authorized by the U.S. Food and Drug Administration. It received FDA approval to use AI to autonomously detect diabetic retinopathy in adults with diabetes, without the need for input from a doctor. Its AI-diagnostic system, the IDx-DR, can be used to identify diabetic retinopathy – one of the leading causes of blindness in the U.S. and other developed countries – as well as other serious eye diseases, including macular edema.